MedPath

A study of endoscopic observations of early gastric cancer at three weeks after vonoprazan following endoscopic therapy

Not Applicable
Conditions
early gastric cancer
Registration Number
JPRN-UMIN000051117
Lead Sponsor
International University of Health and Welfare Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Patients over 90 years of age, patients unable to give consent, other patients considered inappropriate for treatment, and patients with contraindications to vonoprazan.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
esophagogastroduodenoscopy three weeks after endoscopic treatment to evaluate the size of post-endoscopic ulcer, evaluation of ulcer according to the Sakita-Miwa classification.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath